Concepedia

S. Mauss

SM

Statistics

Publications

7

Citations

188

H-Index

7

Active since

2000

Affiliations

Center for HIV and Hepatogastroenterology(Current)

Johns Hopkins University

Boehringer Ingelheim (Germany)

Boehringer Ingelheim (United States)

Hôpital Beaujon

S. Mauss is an author at Center for HIV and Hepatogastroenterology specializing in antiviral therapy, pharmacotherapy, and viral hepatitis.

Publications per year

2000–2016

7

Publications

7

60 SILEN-C1: SUSTAINED VIROLOGIC RESPONSE (SVR) AND SAFETY OF BI201335 COMBINED WITH PEGINTERFERON ALFA-2A AND RIBAVIRIN (P/R) IN TREATMENT-NAIVE PATIENTS WITH CHRONIC GENOTYPE 1 HCV INFECTION

Mark Sulkowski, E. Ceasu, Tarik Asselah et al. · Journal of Hepatology · 2011 · 39 citations

, , +14

HIV-associated lipodystrophy syndrome.

S. Mauss · PubMed · 2000 · 35 citations

66 SILEN-C2: SUSTAINED VIROLOGIC RESPONSE (SVR) AND SAFETY OF BI201335 COMBINED WITH PEGINTERFERON ALFA-2A AND RIBAVIRIN (P/R) IN CHRONIC HCV GENOTYPE-1 PATIENTS WITH NON-RESPONSE TO P/R

Mark Sulkowski, Marc Bourlière, J.‐P. Bronowicki et al. · Journal of Hepatology · 2011 · 30 citations · Full text

, , +12

Estimating the likelihood of sustained virological response in chronic hepatitis C therapy

S. Mauss, D. Hueppe, C John et al. · Journal of Viral Hepatitis · 2010 · 29 citations

, , +17

1190 SILEN-C2: EARLY ANTIVIRAL ACTIVITY AND SAFETY OF BI 201335 COMBINED WITH PEGINTERFERON ALFA-2A AND RIBAVIRIN (PEGIFN/RBV) IN CHRONIC HCV GENOTYPE-1 PATIENTS WITH NON-RESPONSE TO PEGIFN/RBV

Mark Sulkowski, Marc Bourlière, J.‐P. Bronowicki et al. · Journal of Hepatology · 2010 · 22 citations

, , +10

1–5 of 7